Tishcon Corp., a leading
manufacturer and marketer of vitamins, dietary and herbal supplements has
announced that the results of an independent study on the efficacy of the
company's Freedom Softgels® in treating hypertension and
chronic inflammation will be published by Clinical Nutrition,the peer-reviewed publication of the European
Society for Clinical Nutrition and Metabolism.
The acceptance of the
study, published as "A Combined Effect of Cavacurcumin, Eicosapentaenoic acid
(Omega-3s), Astaxanthin and Gamma–linoleic acid (Omega-6) (CEAG) in Healthy
Volunteers - A Randomized, Double-Blind, Placebo-Controlled Study," was
announced jointly by Renee Blaauw, Associate Editor, Clinical
Nutrition (ESPEN) andNicolaas E Deutz, MD, PhD, Editor-in-Chief, Clinical
The study of Freedom
Softgels was conducted by Dr. Matthew Budoff and his team at LA
Biomedical Research Institute Lundquist Institute for Biomedical Innovation at
Harbor-UCLA Medical Center. The study followed 80 individuals (both male and
female) with stage 1 hypertension, in a double-blind, placebo-controlled,
randomized clinical trial. Participants...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).